You are seeing these quotes based on previous browsing related to sectors such as
| Latest | Forecast | |
|---|---|---|
| Div Yield | 3.7% | 3.8% |
| Div Cover | 0.8 | 2.6 |
| Op Mrgn | 17.9% | 33.7% |
| ROCE | 29.7% |
| Latest | Forecast | |
|---|---|---|
| P/E | 32.9 | 1,048.1 |
| PEG | -1.0 | 0.1 |
| Price / Revenue | 5.5 | 2.9 |
| Price / Book value | 3.6 |
| Latest | Forecast | |
|---|---|---|
| Revenue | 1.8% | 77.3% |
| PBT | -34.7% | n/a |
| EPS | -34.0% | 43.9% |
| DPS | 4.8% | 0.7% |
| Year Ending | Revenue ($m) |
Pre-tax ($m) |
EPS | P/E | PEG | EPS Growth | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 2016-12-31 | 52,824.00 | 8,351.00 | $1.18 | 27.5 | 6.2 | 4% | $1.20 | 3.7% |
| 2017-12-31 | 52,546.00 | 12,305.00 | $3.57 | 10.1 | 0.1 | 203% | $1.28 | 3.5% |
| 2018-12-31 | 53,647.00 | 11,885.00 | $1.90 | 22.6 | -0.5 | -47% | $1.38 | 3.2% |
| 2019-12-31 | 41,172.00 | 11,485.00 | $1.91 | 20.5 | 39.0 | 1% | $1.46 | 3.7% |
| 2020-12-31 | 41,908.00 | 7,497.00 | $1.26 | 29.2 | -0.9 | -34% | $1.53 | 4.2% |
| Voyager Therapeutics signs landmark RNA deal with Pfizer Sharecast News | 06 Oct |
|---|---|
| New Covid jab likely to be needed next year - BioNTech chief Sharecast News | 04 Oct |
| Merck and Ridgeback report good results in trial for Covid-19 oral treatment Sharecast News | 01 Oct |